Understanding USP <318>: NMR Spectroscopy for Accurate Monomer Ratio Determination in PLGA Polymers
Summary – Key Takeaways Introduction The introduction of USP <318>: NMR Spectroscopy for Accurate Monomer Ratio Determination in PLGA Polymers […]
Summary – Key Takeaways Introduction The introduction of USP <318>: NMR Spectroscopy for Accurate Monomer Ratio Determination in PLGA Polymers […]
Summary Introduction Accurate determination of PLGA Polymer Molecular Weight and PDI is crucial for judging the quality and performance of
🧭 Introduction: How to Determine Molecular Weight of PLGA Polymers by NMR as per USP <315> The determination of molecular
Introduction: How to Calculate Block Length of PLGA, a Critical Analytical Requirement For many years, laboratories used different approaches for
How to Calculate PLGA Block Length of PLGA: New USP Chapter <319> Sets the Standard Read More »
INTRODUCTION The Lactide:Glycolide ratio is one of the strongest determinants of how a PLGA-based drug delivery system releases its payload
Role of Lactide:Glycolide Ratio (50:50, 75:25, 85:15) in Controlled Release Profiles Read More »
Introduction: Meeting the Demand for High-Purity PCL and PLA Excipients As the pharmaceutical industry advances toward long-acting parenteral and implantable
PCL and PLA Excipients for Parenteral & Implantable Drug Delivery — Supplier Overview Read More »
Summary Introduction: PLGA for Controlled Release and Its Critical Role in Parenteral Systems PLGA for Controlled Release is widely known
PLGA for Controlled-Release Parenteral Formulations — Product Grades & Specifications Read More »
🔍 Summary Introduction: Why Ready-to-Use PLGA for Depot Formulation Is a Game-Changer Ready-to-use PLGA for depot formulation has transformed the
Ready-to-Use PLGA for Depot Formulation, Microencapsulation, and Nanoparticle Systems Read More »
Summary Introduction: Scalable PLGA Contract Manufacturing for Pharmaceutical Innovation As pharmaceutical projects move from lab work to pilot and commercial
Contract Manufacturing of PLGA Excipients for Scale-Up (100 g to Multi-kg) Read More »
INTRODUCTION PLGA molecular weight drug release behavior determines whether a parenteral formulation provides sustained, delayed, or pulsatile delivery. In simple
How PLGA Molecular Weight Impacts Drug Release Kinetics in Parenteral Formulations Read More »